Mr.
Drone is Managing Director and Head of
Houlihan Lokey’s Corporate Valuation Advisory Services practice
as well as
leader
of the
Pharmaceutical and Life Sciences (PLS)
practice.
He
is
a member of the firm's Financial and Valuation Advisory business
leadership team and is based in the New York office.
Prior
to joining Houlihan Lokey, Mr. Drone was
the global leader of PwC’s Deals business for the PLS sector for nearly
a
decade.
Mr. Drone is a seasoned deal consultant with over 25 years of experience advising on
hundreds of transactions representing billions of dollars in
transaction value and/or capital. More specifically,
he advises corporate and private equity clients on the structuring of complex M&A
transactions,
alliances, partnerships,
and
joint ventures,
as
well as minority investments, to
address financial reporting, corporate finance, and valuation issues. In
addition, Mr.
Drone is
a leading advisor within the valuation community on valuation principles, methodologies,
and
critical assumptions employed in various business enterprise, intangible asset,
and
security valuation exercises across the spectrum of life science industries,
including pharmaceuticals, biotech, medical device, diagnostics, generics,
consumer, animal health, healthcare services, contract manufacturers,
and
contract research organizations. His clients range
from startup
biotech
and medical device companies to the largest global life science companies.
Mr.
Drone
holds a
B.S. in Accounting from Bucknell
University and
an MBA in
Finance and Economics from the University of Chicago.
He
is a Certified
Public Accountant and a CFA charterholder.